1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Cancer of Pancreas in 7 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Excerpt | Relevance | Reference |
---|---|---|
" Using whole-cell and cell-attached recording configurations, the role of phosphorylation in leptin activation of ATP-sensitive K+ (KATP) channels was examined in the rat CRI-G1 insulinoma cell line." | 7.70 | Role of tyrosine phosphorylation in leptin activation of ATP-sensitive K+ channels in the rat insulinoma cell line CRI-G1. ( Ashford, ML; Harvey, J, 1998) |
" Using whole-cell and cell-attached recording configurations, the role of phosphorylation in leptin activation of ATP-sensitive K+ (KATP) channels was examined in the rat CRI-G1 insulinoma cell line." | 3.70 | Role of tyrosine phosphorylation in leptin activation of ATP-sensitive K+ channels in the rat insulinoma cell line CRI-G1. ( Ashford, ML; Harvey, J, 1998) |
"The high mortality of pancreatic cancer demands that new therapeutic avenues be developed." | 1.48 | Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth. ( Cutiongco, MF; Gadegaard, N; Jagiełło, A; Kamphorst, JJ; Mackay, G; McGarry, L; Michalopoulou, E; Munro, J; Olson, MF; Pajic, M; Rath, N; Sumpton, D; Timpson, P; Unbekandt, M; Vennin, C, 2018) |
"Pancreatic cancer development and metastasis occur in complex settings, with reciprocal feedback from microenvironmental cues influencing both disease progression and drug response." | 1.46 | Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. ( Adam, AA; Allam, AH; Anderson, KI; Biankin, AV; Boulghourjian, A; Burgess, A; Chantrill, L; Chin, VT; Chou, A; Conway, JR; Cox, TR; Currey, N; Del Monte-Nieto, G; Drury, A; Evans, TR; Froio, D; Gallego-Ortega, D; Gill, AJ; Giry-Laterriere, M; Grey, ST; Harris, NL; Harvey, RP; Herrmann, D; Heu, C; Jain, R; Johns, AL; Kohonen-Corish, M; Lucas, MC; Magenau, A; McCloy, RA; McGhee, EJ; Melenec, P; Morton, JP; Nagrial, AM; Nobis, M; Ormandy, CJ; Pajic, M; Phan, T; Pinese, M; Samra, JS; Samuel, MS; Sansom, OJ; Steinmann, A; Timpson, P; Vennin, C; Walters, SN; Wang, Y; Warren, SC; Weninger, W; Whan, R; Zaratzian, A, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Hosein, AN | 1 |
Brekken, RA | 1 |
Maitra, A | 1 |
Vennin, C | 3 |
Chin, VT | 1 |
Warren, SC | 1 |
Lucas, MC | 1 |
Herrmann, D | 1 |
Magenau, A | 1 |
Melenec, P | 1 |
Walters, SN | 1 |
Del Monte-Nieto, G | 1 |
Conway, JR | 1 |
Nobis, M | 1 |
Allam, AH | 1 |
McCloy, RA | 1 |
Currey, N | 1 |
Pinese, M | 1 |
Boulghourjian, A | 1 |
Zaratzian, A | 1 |
Adam, AA | 1 |
Heu, C | 1 |
Nagrial, AM | 1 |
Chou, A | 1 |
Steinmann, A | 1 |
Drury, A | 1 |
Froio, D | 1 |
Giry-Laterriere, M | 1 |
Harris, NL | 1 |
Phan, T | 1 |
Jain, R | 1 |
Weninger, W | 1 |
McGhee, EJ | 1 |
Whan, R | 1 |
Johns, AL | 1 |
Samra, JS | 1 |
Chantrill, L | 1 |
Gill, AJ | 1 |
Kohonen-Corish, M | 1 |
Harvey, RP | 1 |
Biankin, AV | 1 |
Evans, TR | 1 |
Anderson, KI | 1 |
Grey, ST | 1 |
Ormandy, CJ | 1 |
Gallego-Ortega, D | 1 |
Wang, Y | 1 |
Samuel, MS | 1 |
Sansom, OJ | 1 |
Burgess, A | 1 |
Cox, TR | 1 |
Morton, JP | 1 |
Pajic, M | 3 |
Timpson, P | 3 |
Park, JM | 1 |
Han, YM | 1 |
Jeong, M | 1 |
Chung, MH | 1 |
Kwon, CI | 1 |
Ko, KH | 1 |
Hahm, KB | 1 |
Rath, N | 2 |
Olson, MF | 2 |
Munro, J | 1 |
Cutiongco, MF | 1 |
Jagiełło, A | 1 |
Gadegaard, N | 1 |
McGarry, L | 1 |
Unbekandt, M | 1 |
Michalopoulou, E | 1 |
Kamphorst, JJ | 1 |
Sumpton, D | 1 |
Mackay, G | 1 |
Kaji, M | 1 |
Ishikura, H | 1 |
Kishimoto, T | 1 |
Omi, M | 1 |
Ishizu, A | 1 |
Kimura, C | 1 |
Takahashi, T | 1 |
Kato, H | 1 |
Yoshiki, T | 1 |
Harvey, J | 1 |
Ashford, ML | 1 |
2 reviews available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cancer of Pancreas
Article | Year |
---|---|
Pancreatic cancer stroma: an update on therapeutic targeting strategies.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiogenesis Inhibitors; Animals; Antineoplastic Agen | 2020 |
Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Disease Progression; Humans; Molecular Targe | 2020 |
5 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cancer of Pancreas
Article | Year |
---|---|
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actin Cytoskeleton; Albumin-Bound Paclitaxel; Animals | 2017 |
Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Animals; | 2017 |
Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 2-Hydroxyphenethylamine; Amides; Animals; Antineoplas | 2018 |
E-selectin expression induced by pancreas-carcinoma-derived interleukin-1 alpha results in enhanced adhesion of pancreas-carcinoma cells to endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; CA-19-9 Antigen; Carcinoma; Cell Adhesion; Cell Adhes | 1995 |
Role of tyrosine phosphorylation in leptin activation of ATP-sensitive K+ channels in the rat insulinoma cell line CRI-G1.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Adenylyl Imidodiphosphate; An | 1998 |